AstraZeneca, the big pharma company at the center of takeover speculation, reported a rise in revenues but declining profits for the first quarter.
Heineken, the world's third largest brewer, reported lower than expected increases in beer volumes and revenue on Thursday.
Fracking presents no risk to Novozymes’ bioenergy business, the firm’s CFO told CNBC on Thursday, after it beat first-quarter profit expectations.
Novartis posted first-quarter profit that beat expectations, boosted by an exceptional gain from the sale of its blood transfusion test unit.
Get the best of CNBC in your inbox